MBP and multiple sclerosis: In the past, such a TCRL antibody was selected towards HLA-DR2 molecules complexed with an immunodominant myelin basic protein (MBP) peptide (residues 85–99) and was used for visualization of MBP T-cell epitopes in multiple sclerosis lesions (9).